This Stock is Growing Faster Than Netflix Was At The Same Stage

This stock could see its active users double by 2025 and one analyst says it has “100%-plus” upside potential.

Roku (NASDAQ: ROKU) has been on a tear this year. Shares are up 389% year-to-date, and have surged 48.62% over the last month. 

And according to an analyst at William Blair, Roku’s streaming business is growing at a faster clip than Netflix (NASDAQ: NFLX) was at a similar stage in its life.

“In our view, Roku will experience similar phased stages of international growth as Netflix did during its international expansion,” analyst Ralph Schackart wrote in a note to clients on Tuesday. 

The firm expects Roku’s user base will more than double to 80 million active accounts by 2025.

Roku, which sells streaming devices with thousands of available channels and provides an operating system for smart TVs, topped expectations on its second-quarter earnings report earlier this month. In the report, the company boasted 39% user growth with 30.5 million active users in the quarter, 1.4 million more than it had in Q1. 

Schackart says that Roku’s active account growth is tracking ahead of Netflix at the same stage.

“Looking at Roku’s most recent nine quarters against those of Netflix in the beginning stages of Phase II, Roku, on average, achieved 9% quarter-over-quarter growth, compared with Netflix’s average of 8%,” the analyst wrote.

In addition to the 80 million subscribers Schackart predicts, the analyst estimates Roku’s revenue will reach $4.5 billion by 2025, of which 89% will be earned domestically. That would mean that average revenue per user will reach $58 by 2025, which implies a compound annual growth rate of 16% from 2019 to 2025, according to the firm.

Schackart rates the stock an Outperform and while he doesn’t have an official price target for Roku stock, he says shares have “100%-plus stock upside potential” through 2024.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More